drugset
drugset / Trial / NCT00397176

Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women

NCT00397176 ↗

Phase 1 Completed 32 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedSingle-groupSingle-blindTreatment

Summary

Safety, tolerability, and pharmacokinetics (PK) of desvenlafaxine succinate sustained release (DVS SR) in healthy Japanese female subjects.

Timeline

Start
2006-11
Primary completion
—
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Desvenlafaxine Other / unclassified — Oral

Indications

No indication recorded.